Humanigen Inc (HGENQ)

[cowtown jay]

I've most likely listened to every Durrant interview there is, and read every PR. The only indication I recall that suggests anything beyond 100k vials and $1B in revenue is here:

“Having recently completed enrollment in our Phase 3 clinical trial of lenzilumab, we are also focusing on scalable manufacturing capacity to help ensure access in advance of a potential EUA filing,” said Cameron Durrant, MD, MBA, chief executive officer of Humanigen."

https://www.nasdaq.com/press-release/humanigen-and-avid-bioservices-enter-into-cgmp-manufacturing-agreement-for-covid-19-0

Even in Durrant's television interviews on May 5th, when he was specifically asked by the anchors about what our topline data meant to the company, especially with the outbreaks seen in India and worldwide, Durrant did not expand on our opportunity. In fact, in the CW33 interview, Durrant made clear that our more immediate focus is going to be on the 200 people per day who are contracting Covid in the US.

https://cw33.com/morning-after/humanigen-requesting-emergency-use-authorization-for-covid-19-treament/

https://www.wishtv.com/indy-style/humanigen-ceo-gives-update-on-covid-19-treatment/

Durrant is being as tight-lipped about our demand, ahead of EUA news, as he can possibly be without having his lips sewn shut.

At some point, speculation will be unnecessary, and we will know how much product has been sold, and how much revenue will be raised. Until I get some informed guidance, I stand by what I projected the other day, a Market Cap of $250B, and a share price of $4,200. That's actually assuming that some of these other therapeutics capture a significant portion of the market.